BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 31, 2017
View Archived Issues
New STRN-ALK fusion gene-driven PDTC mouse model developed
Read More
NewLink Genetics initiates phase I study of NLG-802
Read More
Boehringer Ingelheim begins VOLTAIRE-X interchangeability study of adalimumab biosimilar
Read More
Mutant EGFR and/or HER2 inhibitors presented by Ancureall Biomedical Technology
Read More
ITGA7 gene variant discovered to influence risk of proteinopathies
Read More
European Commission approves Vosevi, extends Harvoni indication
Read More
Bristol-Myers Squibb updates clinical and regulatory progress of second quarter 2017
Read More
Roche advances pipeline in second quarter 2017
Read More
MHCSZ-123 antibody offers strong antithrombotic effects by inhibition of collagen binding
Read More
Sumitomo Dainippon offers overview of first quarter of fiscal 2017
Read More
Mitsubishi Tanabe initiates phase IIa trial of MT-8554 in painful diabetic peripheral neuropathy
Read More
Evotec to acquire Aptuit
Read More
Hua Medicine patents mGlu5 receptor antagonists
Read More
Sophia Bioscience divulges histone deacetylase inhibitors
Read More
Raziel intiates phase IIa study of RZL-012 to treat obesity by inducing thermogenesis
Read More
Guangzhou Henovcom Bioscience discovers FXR agonists
Read More
Adenosine A3 receptor antagonists identified at Handok
Read More
Otsuka files for Japanese approval of ASC-01 for major depressive disorder
Read More
Sperovie Biosciences patents PDE4B and/or TNF-alpha release inhibitors
Read More
Kyowa Hakko Kirin updates U.S. and E.U. regulatory progress of burosumab
Read More
European Commission approves AbbVie's Maviret for chronic HCV genotypes 1-6
Read More
FDA advisory committee votes in favor of Heplisav-B
Read More
FDA approves Abilify Maintena for maintenance treatment of bipolar I disorder
Read More
KPM-2 shows promise in cancer and neurodegenerative disorders
Read More
CytRx and NantCell sign strategic license for aldoxorubicin
Read More
FDA grants breakthrough therapy designation to Imfinzi for locally advanced unresectable NSCLC
Read More
Tenax reviews options after FDA requests additional clinical trial for levosimendan
Read More